Pharmacotherapy of intraocular inflammation and conjunctivitis

Author： DempeChristian   AugustinAlbert J.  

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.3, Iss.5, 2015-09, pp. : 378-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ranibizumab: Intraocular inflammation following intravitreal administration in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 38-39

Adis International

Access to resources Recommend Favorite

Bevacizumab: Intraocular inflammation following intravitreal administration: case report

By  

Reactions Weekly, Vol. 1, Iss. 1340, 2011-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Ranibizumab: Intraocular inflammation following intravitreal administration in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Bevacizumab/ranibizumab: Intraocular inflammation following intravitreal administration: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of intraocular pressure – part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

By Costagliola Ciro   dell’Omo Roberto   Romano Mario R   Rinaldi Michele   Zeppa Lucia   Parmeggiani Francesco  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2859-2870

Informa Healthcare

Access to resources Recommend Favorite